Modeyso

Active Ingredient(s): Dordaviprone Hydrochloride
FDA Approved: * August 6, 2025
Pharm Company: * CHIMERIX
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Modeyso 125 mg Oral Capsule
NDC: 68727-250
Labeler:
Jazz Pharmaceuticals, Inc.